Feel Therapeutics, a company focused on making mental health care more science-forward, recently raised $3.5 million in funding. The company’s pitch deck, which consists of 11 slides, provides a comprehensive overview of their products and goals. While the deck showcases some strengths, there are also areas where improvements could be made.
One of the standout aspects of Feel Therapeutics’ pitch deck is its originality. The company takes a unique approach to storytelling, starting with the question of why mental health isn’t tracked as extensively as physical health. By framing their pitch in this way, Feel Therapeutics immediately captures the reader’s attention and highlights the need for their products.
Additionally, the company does an excellent job of providing an overview of their business on one slide. This is particularly impressive considering the complexity of their platform. By starting with a broad view and gradually adding more details, Feel Therapeutics ensures that investors can easily follow along and understand their value proposition.
Furthermore, Feel Therapeutics includes a slide showcasing their traction, which is crucial for demonstrating progress. With 2,700 patients across nine countries, the company has a substantial sample size to prove the efficacy of their product. However, it’s important to note that some of the medical jargon used on this slide may confuse investors. Simplifying or explaining these terms would make the slide more accessible to a wider audience. Additionally, including a timeline or progress graph would enhance the narrative by illustrating growth and momentum. Furthermore, including financial performance data would provide a more complete picture of Feel Therapeutics’ traction and business potential.
While Feel Therapeutics’ pitch deck has its strengths, there are also areas where improvements could be made. The deck lacks information on competition, go-to-market plans, and operating plans. These are crucial aspects that investors would like to see in order to assess the company’s viability and potential for success. It would have been beneficial for Feel Therapeutics to mention their business model, pricing strategy, target customers, and unit economics. Additionally, including specific financial goals and deadlines in the “Use of Funds” section would provide investors with a clearer understanding of how the funds will be utilized.
Another area that could be improved is the team slide. While the slide includes impressive names and titles, it doesn’t clearly explain why these individuals are the right fit to lead the company. Clarifying their roles and contributions would give investors a better sense of their involvement in the company’s operations. Instead of focusing on publications and citations, highlighting specific achievements and experiences that directly relate to Feel Therapeutics’ goals would be more impactful.
Furthermore, it’s worth noting that Feel Therapeutics has raised $30 million in funding to date. While this demonstrates investor interest, it also raises questions about the company’s growth and financial health. Investors would want to understand why the company hasn’t reached proper growth yet and what steps have been taken to address this. Additionally, a thorough examination of the company’s cap table and founders’ involvement would be necessary for due diligence.
Overall, Feel Therapeutics’ pitch deck provides valuable insights into their products and goals. By addressing the areas for improvement mentioned above, the company can strengthen their pitch and increase their chances of securing further funding.